Director Felix Carbullido resigns from Abercrombie & Fitch board for Williams Sonoma role

ABERCROMBIE & FITCH CO /DE/

Felix Carbullido stepping down effective August 1, 2022, due to new appointment as President of the Williams Sonoma brand.
Board size reduced from 11 to 10 members; no replacement announced.
Carbullido served three years, including on Compensation/Human Capital and ESG committees; chairman thanks him.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Felix Carbullido

Director

ANF · ABERCROMBIE & FITCH CO /DE/

Effective: 2022-08-01
Filed: August 1, 2022, 7:59 PM ET

On July 26, 2022, Felix Carbullido notified Abercrombie & Fitch Co. (the “Company”) of his intention to step down as a member of the Company’s Board of Directors (the “Board”), effective August 1, 2022 (the “Effective Date”), in connection with his newly appointed role as President of the Williams Sonoma brand of Williams-Sonoma, Inc.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Felix Carbullido resigned as Director at ABERCROMBIE & FITCH CO /DE/.

Action: resigned
Role: Director

Exact text from the filing

On July 26, 2022, Felix Carbullido notified Abercrombie & Fitch Co. (the “Company”) of his intention to step down as a member of the Company’s Board of Directors (the “Board”), effective August 1, 2022 (the “Effective Date”), in connection with his newly appointed role as President of the Williams Sonoma brand of Williams-Sonoma, Inc.

View on SEC.gov

ABERCROMBIE & FITCH CO /DE/ filing history →

Source: SEC EDGAR

accession 0001018840-22-000042

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.